Project-specific health-based exposure limit and occupational toxicology assessment support. The agreed scope may include PDE/ADE derivation, OEL derivation and OEB/OHC banding, based on the exact substance form, available evidence and intended product or workplace context.
Ioxitalamate is a water-soluble ionic tri-iodinated contrast agent. Its iodine atoms attenuate X-rays, increasing radiographic contrast in vascular and other extracellular spaces. Meglumine and sodium salts are formulation counterions; the labelled contrast formulation determines route and indication.
Indications / reported uses
Radiographic contrast enhancement for angiography, urography and other X-ray or CT examinations according to the specific salt, formulation and product label.
Oral or rectal contrast use in selected gastrointestinal imaging protocols with products specifically labelled for those routes.
Scope is agreed for the exact substance form, intended use, exposure route, workplace context and available toxicological evidence.
PDE/ADE: critical effects, point of departure and justified adjustment factors.
OEL: inhalation hazards, exposure duration and workplace conditions.
OEB/OHC: evidence-based banding where requested; a band is not a numerical OEL.
Report: scientific rationale, source data, assumptions, uncertainties and limitations.
Assessment scope
PDE/ADE and OEL/OEB assessment
ReguSight provides project-specific support for Ioxitalamate PDE/ADE, OEL and OEB/OHC assessments. This combined profile covers the Ioxitalamate Permitted Daily Exposure (PDE) report (the Ioxitalamate PDE report); Acceptable Daily Exposure (ADE) is the corresponding health-based daily exposure terminology. It also covers the Ioxitalamate Occupational Exposure Limit (OEL) report (the Ioxitalamate OEL report). PDE/ADE derivation and workplace exposure assessment are distinct scientific outputs; a band is not a numerical OEL.
Assessment may cover
PDE/ADE derivation using relevant toxicological evidence, critical effects, a justified point of departure and adjustment factors.
The EMA HBEL guideline informs PDE/ADE assessments in relevant shared-facility contexts. ECHA and HSE sources address workplace exposure limits; NIOSH provides occupational exposure-banding guidance. The applicable framework depends on the assessment question and jurisdiction.